This content is only available within our institutional offering.
06 Sep 2016
PANMURE: Revised estimates and continuing clinical progress
Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
PANMURE: Revised estimates and continuing clinical progress
Faron Pharmaceuticals Oy (FARN:LON) | 58.5 3.8 12.5% | Mkt Cap: 67.7m
- Published:
06 Sep 2016 -
Author:
Julie Simmonds -
Pages:
7 -